Trial intelligence / Profile preview

Dexamethasone Palmitate for PONV Prophylaxis

NCT06981754Completed

Sponsor
Beijing Tiantan Hospital
Start
Jun 2025
Primary completion
Apr 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Jun 2025; status: completed.

02

Drugs

dexamethasone
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT06981754.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06981754.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call